Aric Sharp Announced as Divisional CEO of Value Based Care for Clover Health
May 09 2022 - 4:02PM
Clover Health Investments, Corp. (NASDAQ: CLOV) (“Clover” or
“Clover Health”), a physician enablement company committed to
improving health equity for seniors, today announced the
appointment of Aric Sharp as Chief Executive Officer (“CEO”) of
Value Based Care for Clover. Sharp will spearhead all value based
care operations for the company including for Clover Health
Partners, Clover’s Direct Contracting Entity (“DCE”).
Sharp is recognized as a national leader on the healthcare
transition to value, innovation, and physician practice management
and is Chair-Elect of the American Medical Group Association. In
his former role as Senior Vice President and Chief Transformation
Officer at INTEGRIS Health, he led the system's journey to value
based care including launching INTEGRIS’ participation in the
Direct Contracting Model, a Medicare Advantage Plan, and Oklahoma’s
first virtual hospital.
Sharp will begin by overseeing the transition of Clover Health
Partners to fit the requirements of the evolved Accountable Care
Organization (“ACO”) Realizing Equity, Access, and Community Health
(“REACH”) Model, which will take effect in 2023.
“We are thrilled to welcome Aric to the Clover family, and
believe his experience leading transformation efforts for payor
innovation strategies around value based agreements will position
him well to lead Clover Health Partners through its transition to
the ACO REACH Model,” said Clover CEO Vivek Garipalli.
“Additionally, Aric’s expertise in physician relations and ability
to strategize and operationalize with a keen focus on provider
education, buy-in and engagement will be a huge asset to Clover as
we look to broaden our provider network and adoption of the Clover
Assistant.”
Prior to INTEGRIS, Sharp served as Vice President for
Accountable Care at UnityPoint Health, where he developed and led
UnityPoint Accountable Care, one of the nation’s largest and most
successful ACOs, with over 8,000 physicians, 40 hospitals, and over
$1.5 billion of medical spend under risk including the country’s
largest Next-Generation ACO Model. Earlier in his career, Sharp
served in various executive roles including CEO and Chief Operating
Officer for Quincy Medical Group and The Iowa Clinic, respectively,
two of the nation’s highest-performing multispecialty medical
groups.
“I am excited to join Clover because I see an opportunity to
develop and implement a myriad of value based care and population
health initiatives to further strengthen the company’s existing DCE
efforts. My primary goal is to supercharge network growth and
adoption of Clover’s physician enablement technology to make value
based care more accessible for physicians across the country, and
therefore more patients,” said Sharp.
About Clover Health:Clover Health (Nasdaq:
CLOV) is a physician enablement company focused on seniors who have
historically lacked access to affordable, high-quality healthcare.
Our strategy is underpinned by our proprietary software platform,
the Clover Assistant, which is designed to aggregate patient data
from across the health ecosystem to support clinical
decision-making and improve health outcomes. We operate two
distinct lines of business: Insurance and Non-Insurance. Through
its Insurance segment, the company provides PPO and HMO plans to
Medicare Advantage members in several states. The company's
Non-Insurance segment consists of its operations in connection with
its participation in CMS' Direct Contracting model, which will
transition to the ACO REACH model beginning in 2023. Clover’s
corporate headquarters are in Franklin, Tenn.
Visit: www.cloverhealth.comRead about our Health Equity
strategy: www.cloverhealth.com/healthequity Learn about the Clover
Assistant: www.cloverassistant.com
Forward-Looking Statements:This press release
contains forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended. Forward-looking
statements include statements regarding future events and Clover’s
future results of operations, financial position, market size and
opportunity, business strategy and plans, and the factors affecting
Clover’s performance and objectives for future operations.
Forward-looking statements are not guarantees of future performance
and you are cautioned not to place undue reliance on such
statements. In some cases, you can identify forward looking
statements because they contain words such as “may,” “will,”
“should,” “expects,” “plans,” “anticipates,” “going to,” “can,”
“could,” “should,” “would,” “intends,” “target,” “projects,”
“contemplates,” “believes,” “estimates,” “predicts,” “potential,”
“outlook,” “forecast,” “guidance,” “objective,” “plan,” “seek,”
“grow,” “target,” “if,” “continue” or the negative of these words
or other similar terms or expressions that concern Clover’s
expectations, strategy, priorities, plans or intentions. Additional
information concerning these and other risk factors is contained in
the Risk Factors section included in Clover’s Annual Report on Form
10-K for the year ended December 31, 2021, which was filed with the
Securities and Exchange Commission (the “SEC”) on February 28,
2022, and in Clover’s other filings with the SEC. The
forward-looking statements included in this release are made as of
the date hereof. Except as required by law, Clover undertakes no
obligation to update any of these forward-looking statements after
the date of this press release or to conform these statements to
actual results or revised expectations.
Press Contact:Andrew
Still-Baxterpress@cloverhealth.com
Investor Relations:Derrick Nueman & Ryan
Schmidtinvestors@cloverhealth.com
Clover Health Investments (NASDAQ:CLOV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Clover Health Investments (NASDAQ:CLOV)
Historical Stock Chart
From Apr 2023 to Apr 2024